VIATRIS INC (VTRS)

Watsco Larger Than S&P 500 Component Viatris

XPO Larger Than S&P 500 Component Viatris

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S....

BTIG Research Predicts Over 118% Rally for These 3 Stocks

Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money.

Viatris Appoints Corinne Le Goff as Chief Commercial Officer

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Corinne Le Goff has joined the company as Chief Commercial...

Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada

/CNW/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the launch in Canada of PrGlatiramer Acetate Injection 20 mg/mL for...

Dynatrace Larger Than S&P 500 Component Viatris

Steady Returns Ahead: 3 Dividend Stocks for Stable Income in Q2

Discover three top dividend stocks for stable income in April that combine sustainable returns and long-term growth.

Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the U.S. commercial launch of RYZUMVI™ (phentolamine ophthalmic...

Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline

/PRNewswire/ -- At a meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will outline how it is continuing...

Is Viatris a Great Dividend Stock or Just a Value Trap?

Investors can collect a high yield with Viatris, but is it a risky payout to rely on?

2 Dirt Cheap Dividend Stocks to Buy and Hold

These companies aren't popular on the market right now, but income investors will like them.

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris

Wednesday Sector Laggards: Healthcare, Energy

Viatris tops estimates in 2024 outlook, boosts share buybacks

Viatris (VTRS) announces Q4 2023 financials, misses revenue forecasts but sets an optimistic revenue outlook for 2024. Read more here.

Viatris EPS of -$0.64, revenue of $3.83B misses by $50M (NASDAQ:VTRS)

Viatris (VTRS) reports Q4 EPS of -$0.64, missing consensus, and revenue of $3.83B, which is down 1.0% year-over-year and misses by $50M.

Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

/PRNewswire/ -- Meets 2023 Guidance for Total Revenues, Adjusted EBITDA and Free Cash Flow[1] Reports 2023 Total Revenues of $15.4 Billion, U.S. GAAP Net...

Viatris secures right for two late-stage drug assets in Idorsia pact (NASDAQ:VTRS)

Viatris secures exclusive global rights to two late-stage drug candidates in partnership with Idorsia, expanding their portfolio for future revenue growth.

Viatris secures right to late-stage drug assets in Idorsia pact (NASDAQ:VTRS)

Viatris secures exclusive global rights to two late-stage drug candidates in partnership with Idorsia, expanding their portfolio for future revenue growth.

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration

Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selatogrel and Cenerimod, Both With Blockbuster Revenue Potential...

3 Overextended Stocks That Need to Slash Their Dividends ASAP

The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big.

Viatris Q4 2023 earnings preview: Margins remain under pressure (NASDAQ:VTRS)

Viatris (VTRS) is scheduled to announce Q4 earnings results on Wednesday, February 28th, before market open. The consensus EPS Estimate is $0.65 and the consens

3 Bargain Stocks to Snatch Up Before They Bounce Back

The market is a weighing machine in the long run, meaning these bargain stocks will deliver impressive forward returns.

Viatris stock set for seven straight sessions of gains (NASDAQ:VTRS)

jamesbenet Viatris (NASDAQ:VTRS) is on track for a seven-day winning streak, gaining 11.8% over the last six trading sessions.

Glenview Capital takes in Marvell, cuts stake in Intel and exits Microsoft (NASDAQ:MRVL)

Glenview Capital Management took new positions in Marvell Technology (MRVL) and CVS Health (CVS) in Q4 2023. Read more here.

Greenlight Capital buys Alight, exits Southwestern Energy

Hedge fund Greenlight Capital's latest 13F filing reveals additions of Alight Inc., Viatris, and AerCap, while exiting Southwestern Energy.

Commit To Purchase Viatris At $8, Earn 4.4% Using Options

Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will announce its fourth quarter and full-year 2023 financial results Wednesday, Feb. 28, 2024, before the open of...

Alight, Viatris gain after Greenlight discloses position in Q4 letter (NYSE:ALIT)

Alight and Viatris shares rise after hedge fund Greenlight reveals stake in Q4 letter to investors.

Theravance, Mylan settle Yupelri patent dispute with Orbicular

Theravance Biopharma (TBPH) and Viatris (VTRS) unit, Mylan settle patent dispute over generic Yupelri with Orbicular Pharmaceutical Technologies, Read more here.

These 9 Stocks Are Running To Start 2024

The S&P 500 is up just 0.2% in 2024. These stocks are off to a strong start.